{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:13:40Z","timestamp":1791288820367,"version":"4.3.0"},"reference-count":63,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013885","name":"Ministry of Health Malaysia","doi-asserted-by":"crossref","award":["91000050"],"award-info":[{"award-number":["91000050"]}],"id":[{"id":"10.13039\/501100013885","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,9,28]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Metabolic syndrome (MetS) is a cluster of cardio-metabolic dysfunctions characterised by increased fasting plasma glucose, waist circumference, blood pressure, triglycerides and reduction in high-density lipoprotein cholesterol. Meanwhile, metabolic dysfunction-associated fatty liver disease (MAFLD) is the new term for fatty liver associated with MetS. People with MetS or MAFLD have higher risks for adverse cardiovascular outcomes and mortalities. However, large-scale data on MetS and MAFLD prevalence in Malaysia is mainly unknown. This study aims to determine the prevalence of MetS and MAFLD among the general adult population in Malaysia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      This is a community-based nationwide cross-sectional study in Malaysia. The data collection period is from July 2023 until September 2023, with a planned sample size of 1296 participants. We use a two-stage proportionate stratified random sampling method to ensure national representativeness. The definition of MetS follows the Harmonised Joint Interim Statement in 2009. A diagnosis of MAFLD is made if a participant has fatty liver, defined as having a Fatty Liver Index \u226560 and has type 2 diabetes, a body mass index \u226523\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , or \u22652 metabolic risk abnormalities. Complex sample analysis will be conducted, and the disease prevalence will be reported with 95% CIs, unweighted counts and estimated populations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The protocol has been approved by the Medical Research and Ethics Committee of the Ministry of Health Malaysia (NMRR ID-22\u201302845-GUT). The findings will be disseminated through a formal report, policy brief, scientific publications, conference presentations, social media, print media and stakeholder engagement activities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-074432","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T09:35:31Z","timestamp":1698399331000},"page":"e074432","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of metabolic syndrome and metabolic dysfunction-associated fatty liver disease in Malaysia 2023: study protocol for a community-based nationwide cross-sectional survey"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0859-1648","authenticated-orcid":false,"given":"Kim Sui","family":"Wan","sequence":"first","affiliation":[{"name":"Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5067-5677","authenticated-orcid":false,"given":"Halizah","family":"Mat Rifin","sequence":"additional","affiliation":[{"name":"Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Fadhli","family":"Mohd Yusoff","sequence":"additional","affiliation":[{"name":"Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishwen Kanna","family":"Yoga Ratnam","sequence":"additional","affiliation":[{"name":"Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wah Kheong","family":"Chan","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masni","family":"Mohamad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Putrajaya Hospital, Ministry of Health Malaysia, Putrajaya, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurain","family":"Mohd Noor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Putrajaya Hospital, Ministry of Health Malaysia, Putrajaya, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feisul","family":"Mustapha","sequence":"additional","affiliation":[{"name":"Disease Control Division, Ministry of Health Malaysia, Putrajaya, Malaysia"},{"name":"Perak State Health Department, Ministry of Health Malaysia, Perak, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Ani","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"2025121511453256000_13.10.e074432.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"2025121511453256000_13.10.e074432.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.034"},{"key":"2025121511453256000_13.10.e074432.3","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12075"},{"key":"2025121511453256000_13.10.e074432.4","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"2025121511453256000_13.10.e074432.5","doi-asserted-by":"publisher","DOI":"10.1161\/circ.106.25.3143"},{"key":"2025121511453256000_13.10.e074432.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67402-8"},{"key":"2025121511453256000_13.10.e074432.7","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0812-z"},{"key":"2025121511453256000_13.10.e074432.8","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4041-1"},{"key":"2025121511453256000_13.10.e074432.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1595"},{"key":"2025121511453256000_13.10.e074432.10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.diabres.2010.11.025","article-title":"Prevalence of metabolic syndrome and its risk factors in adult Malaysians: results of a nationwide survey","volume":"91","author":"Mohamud","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"2025121511453256000_13.10.e074432.11","first-page":"20","article-title":"A review of metabolic syndrome research in Malaysia","volume":"71","author":"Lim","year":"2016","journal-title":"Med J Malaysia"},{"key":"2025121511453256000_13.10.e074432.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762"},{"key":"2025121511453256000_13.10.e074432.13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2025121511453256000_13.10.e074432.14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/jgh.15787","article-title":"Malaysian society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease","volume":"37","author":"Chan","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"2025121511453256000_13.10.e074432.15","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.149"},{"key":"2025121511453256000_13.10.e074432.16","doi-asserted-by":"crossref","unstructured":"Y\u0131lmaz Y . The heated debate over NAFLD renaming: an ongoing saga. Hepatology Forum 2023. doi:10.14744\/hf.2023.2023.0044","DOI":"10.14744\/hf.2023.2023.0044"},{"key":"2025121511453256000_13.10.e074432.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039"},{"key":"2025121511453256000_13.10.e074432.18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","article-title":"An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD","volume":"21","author":"Lim","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121511453256000_13.10.e074432.19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eprac.2022.03.016","article-title":"Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A meta-analysis and systematic review of 12\u2009620\u2009736 individuals","volume":"28","author":"Quek","year":"2022","journal-title":"Endocr Pract"},{"key":"2025121511453256000_13.10.e074432.20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/liv.15139","article-title":"Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: focusing on the non-overlap groups","volume":"42","author":"Ayada","year":"2022","journal-title":"Liver Int"},{"key":"2025121511453256000_13.10.e074432.21","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic associated fatty liver disease. A meta-analysis and systematic review of 10,739,607 individuals","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121511453256000_13.10.e074432.22","doi-asserted-by":"crossref","unstructured":"Wen W , Li H , Wang C , et al . Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: a meta-analysis. Front Endocrinol (Lausanne) 2022;13. doi:10.3389\/fendo.2022.934225","DOI":"10.3389\/fendo.2022.934225"},{"key":"2025121511453256000_13.10.e074432.23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12944-022-01659-1","article-title":"Association between the severity of metabolic dysfunction-associated fatty liver disease and the risk of colorectal neoplasm: a systematic review and meta-analysis","volume":"21","author":"Zeng","year":"2022","journal-title":"Lipids Health Dis"},{"key":"2025121511453256000_13.10.e074432.24","doi-asserted-by":"crossref","unstructured":"Hegyi PJ , V\u00e1ncsa S , Ocskay K , et al . Metabolic associated fatty liver disease is associated with an increased risk of severe COVID-19: a systematic review with meta-analysis. Front Med (Lausanne) 2021;8. doi:10.3389\/fmed.2021.626425","DOI":"10.3389\/fmed.2021.626425"},{"key":"2025121511453256000_13.10.e074432.25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5114\/ceh.2021.109228","article-title":"Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis","volume":"7","author":"Dyah","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"2025121511453256000_13.10.e074432.26","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121511453256000_13.10.e074432.27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2468-1253(21)00002-9","article-title":"Endorsing the redefinition of fatty liver disease","volume":"6","author":"Tan","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121511453256000_13.10.e074432.28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2020.12.016","article-title":"Clinical utility of the MAFLD definition","volume":"74","author":"Zheng","year":"2021","journal-title":"J Hepatol"},{"key":"2025121511453256000_13.10.e074432.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.035"},{"key":"2025121511453256000_13.10.e074432.30","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121511453256000_13.10.e074432.31","unstructured":"Department of Statistics Malaysia . Living quarters 2023. 2023. Available: https:\/\/dev.dosm.gov.my\/assets\/documents\/living.pdf [Accessed 18 Sep 2023]."},{"key":"2025121511453256000_13.10.e074432.32","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002633"},{"key":"2025121511453256000_13.10.e074432.33","unstructured":"Ministry of Health Malaysia . Malaysian Guideline for Good Clinical Practice. 4th edition. 2018. Available: https:\/\/www.crc.gov.my\/wp-content\/uploads\/2018\/03\/Malaysian_gcp_4th_Edition28Final_29.pdf"},{"key":"2025121511453256000_13.10.e074432.34","unstructured":"Israel GD . Determining sample size: University of Florida cooperative extension service. EDIS Institute of food and Agriculture sciences; 1992."},{"key":"2025121511453256000_13.10.e074432.35","doi-asserted-by":"crossref","unstructured":"Serdar CC , Cihan M , Y\u00fccel D , et al . Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb) 2021;31. doi:10.11613\/BM.2021.010502","DOI":"10.11613\/BM.2021.010502"},{"key":"2025121511453256000_13.10.e074432.36","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9359-2"},{"key":"2025121511453256000_13.10.e074432.37","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.pbj.0000000000000031","article-title":"Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang valley, Malaysia: an observational cross-sectional study","volume":"4","author":"Khammas","year":"2019","journal-title":"Porto Biomed J"},{"key":"2025121511453256000_13.10.e074432.38","unstructured":"Department of Statistics Malaysia . Current population estimates. Malaysia Putrajaya; 2021."},{"key":"2025121511453256000_13.10.e074432.39","unstructured":"Institute for Public Health . National health and morbidity survey (NHMS) 2019: vol 1: Ncds - non-communicable diseases: risk factors and other health problems; 2020."},{"key":"2025121511453256000_13.10.e074432.40","unstructured":"Department of Statistics Malaysia . Key findings population and housing census of Malaysia, 2020 version 2.0. Malaysia Putrajaya; 2022."},{"key":"2025121511453256000_13.10.e074432.41","doi-asserted-by":"crossref","unstructured":"Ramli AS , Daher AM , Nor-Ashikin MNK , et al . JIS definition identified more Malaysian adults with metabolic syndrome compared to the NCEP-ATP III and IDF criteria. Biomed Res Int 2013;2013. doi:10.1155\/2013\/760963","DOI":"10.1155\/2013\/760963"},{"key":"2025121511453256000_13.10.e074432.42","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15092031","article-title":"Prevalence of metabolic syndrome and its associated factors among vegetarians in Malaysia","volume":"15","author":"Ching","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"2025121511453256000_13.10.e074432.43","doi-asserted-by":"crossref","unstructured":"Iqbal SP , Ramadas A , Fatt QK , et al . Relationship of Sociodemographic and lifestyle factors and diet habits with metabolic syndrome (Mets) among three ethnic groups of the Malaysian population. PLoS One 2020;15. doi:10.1371\/journal.pone.0224054","DOI":"10.1371\/journal.pone.0224054"},{"key":"2025121511453256000_13.10.e074432.44","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1038\/s41598-021-87248-1","article-title":"Prevalence of metabolic syndrome and its associated risk factors among staffs in a Malaysian public University","volume":"11","author":"Manaf","year":"2021","journal-title":"Sci Rep"},{"key":"2025121511453256000_13.10.e074432.45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-6-33"},{"key":"2025121511453256000_13.10.e074432.46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"European Association for the study of the liver, European Association for the study of diabetes. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"9","year":"2016","journal-title":"Obes Facts"},{"key":"2025121511453256000_13.10.e074432.47","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3390\/jcm10091877","article-title":"Performance of fatty liver index in identifying non-alcoholic fatty liver disease in population studies. a meta-analysis","volume":"10","author":"Castellana","year":"2021","journal-title":"J Clin Med"},{"key":"2025121511453256000_13.10.e074432.48","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.127","article-title":"The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease","volume":"3","author":"Hernandez Roman","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"2025121511453256000_13.10.e074432.49","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121511453256000_13.10.e074432.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"2025121511453256000_13.10.e074432.51","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J Gastroenterol"},{"key":"2025121511453256000_13.10.e074432.52","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.005"},{"key":"2025121511453256000_13.10.e074432.53","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.21037\/atm-20-2951","article-title":"Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance","volume":"8","author":"Jeong","year":"2020","journal-title":"Ann Transl Med"},{"key":"2025121511453256000_13.10.e074432.54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250300","article-title":"Attenuation parameter and liver stiffness measurement using fibrotouch vs Fibroscan in patients with chronic liver disease","volume":"16","author":"Ng","year":"2021","journal-title":"PLoS One"},{"key":"2025121511453256000_13.10.e074432.55","doi-asserted-by":"crossref","unstructured":"Rinella ME , Lazarus JV , Ratziu V , et al . A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023. doi:10.1097\/HEP.0000000000000520","DOI":"10.1097\/HEP.0000000000000696"},{"key":"2025121511453256000_13.10.e074432.56","unstructured":"Institute for Public Health . Welcome to Institute for public health centre for Epidemiological survey research. 2022. Available: https:\/\/iku.gov.my [Accessed 22 Jan 2023]."},{"key":"2025121511453256000_13.10.e074432.57","unstructured":"Institute for Public Health . Welcome to NHMS national health & morbidity survey. 2023. Available: https:\/\/iku.gov.my\/nhms [Accessed 22 Jan 2023]."},{"key":"2025121511453256000_13.10.e074432.58","unstructured":"World Health Organization, Noncommunicable D, Mental Health C . Who Steps Surveillance Manual: the Who Stepwise Approach to Chronic Disease Risk Factor Surveillance \/ Noncommunicable Diseases and Mental Health, World Health Organization. Geneva: World Health Organization, 2005."},{"key":"2025121511453256000_13.10.e074432.59","first-page":"675","article-title":"Reliability, technical error of measurement and validity of height measurement using portable stadiometer","volume":"25","author":"Baharudin","year":"2017","journal-title":"Pertanika J Sci & Technol"},{"key":"2025121511453256000_13.10.e074432.60","first-page":"1013","article-title":"Reliability, technical error of measurements and validity of instruments for nutritional status assessment of adults in Malaysia","volume":"50","author":"Geeta","year":"2009","journal-title":"Singapore Med J"},{"key":"2025121511453256000_13.10.e074432.61","doi-asserted-by":"publisher","DOI":"10.1097\/00126097-200208000-00006"},{"key":"2025121511453256000_13.10.e074432.62","unstructured":"Ministry of International Trade and Industry (MITI) . Testing & calibration laboratories (SAMM). 2022. Available: https:\/\/www.jsm.gov.my\/accreditation\/get-accredited\/fields-programmes [Accessed 29 Nov 2022]."},{"key":"2025121511453256000_13.10.e074432.63","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-50"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-074432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:45:44Z","timestamp":1765827944000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-074432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":63,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,27]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bmjopen-2023-074432"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-074432","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}